CT-guided High-Dose-Rate Brachytherapy versus Transarterial Chemoembolization in Patients with Unresectable Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

CT-guided High-Dose-Rate Brachytherapy versus Transarterial Chemoembolization in Patients with Unresectable Hepatocellular Carcinoma

Published:2024-02-01 Issue:2 Volume:310 Page:
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Auer Timo A.^ORCID,Müller Lukas^ORCID,Schulze Daniel^ORCID,Anhamm Melina^ORCID,Bettinger Dominik^ORCID,Steinle Verena,Haubold Johannes^ORCID,Zopfs David^ORCID,Pinto dos Santos Daniel^ORCID,Eisenblätter Michel,Gebauer Bernhard^ORCID,Kloeckner Roman^ORCID,Collettini Federico^ORCID

Publisher

Radiological Society of North America (RSNA)

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.232044

Reference25 articles.

1. Epidemiology and surveillance for hepatocellular carcinoma: New trends

2. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update

3. Patient Selection for Transarterial Chemoembolization in Hepatocellular Carcinoma: Importance of Benefit/Risk Assessment

4. Risk factors and therapeutic results of early local recurrence after transcatheter arterial chemoembolization

5. CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I–II results of a novel technique

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. INTERVENTION – Inoperables HCC: Hochdosis-Brachytherapie versus TACE;RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren;2024-08-15

2. AI-derived body composition parameters as prognostic factors in patients with HCC undergoing TACE in a multicenter study;JHEP Reports;2024-08

3. Effectiveness and safety of computed tomography-guided high-dose-rate brachytherapy in treating recurrent hepatocellular carcinoma not amenable to repeated resection or radiofrequency ablation;European Journal of Surgical Oncology;2024-07

4. Diagnostik und Therapie von hepatobiliären Tumoren;InFo Hämatologie + Onkologie;2024-06

5. Sulfonated Azocalix[4]arene-Modified Metal–Organic Framework Nanosheets for Doxorubicin Removal from Serum;Nanomaterials;2024-05-16